Syndax Pharmaceuticals SNDX Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's cash ratio?
- Syndax Pharmaceuticals (SNDX) reported cash ratio of 1.5× in Q1 2026.
- How has Syndax Pharmaceuticals's cash ratio changed year-over-year?
- Syndax Pharmaceuticals's cash ratio decreased by 6.7% year-over-year, from 1.6× to 1.5×.
- What is the long-term trend for Syndax Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Syndax Pharmaceuticals's cash ratio has grown at a -28.7% compound annual growth rate (CAGR), from 6.1× to 1.1×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.